GlassScriptPhysician profile
Matthew P Branch
NPI 1194798744
$1,807.73
in general payments reported to CMS, 2019-2025
16 companies · $246 in 2025
The $246 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $744 · 2020: $14.16 · 2021: $292 · 2022: $70.54 · 2023: $357 · 2024: $83.93 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $687.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $1,065.15 | 2019-2024 | Trudi Nav Cable, Relieva Spinplus |
| Regeneron Healthcare Solutions, INC. | $190.17 | 2023-2025 | Dupixent |
| Stryker Corporation | $143.72 | 2019-2022 | |
| Glaxosmithkline, LLC. | $78.35 | 2025 | Nucala |
| Aerin Medical INC. | $51.79 | 2019-2023 | |
| Neurent Medical Limited | $45.76 | 2022-2023 | Neuromark Device, Neuromark Radiofrequency Console |
| Medtronic, INC. | $42.65 | 2023-2025 | Propel |
| Phathom Pharmaceuticals, INC. | $27.68 | 2025 | Voquezna |
| Xoran Technologies LLC | $26.50 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $24.63 | 2024 | Exparel |
| Integra Lifesciences Corporation | $22.81 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Genzyme Corporation | $20.44 | 2025 | |
| Spirair, INC. | $18.63 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $18.22 | 2025 | Tezspire |
| Ethicon US, LLC | $18.03 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arrinex, INC. | $13.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Branch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.